Skip to main content
. 2016 Feb 26;7(21):31572–31585. doi: 10.18632/oncotarget.7765

Table 1. Role of key multifaceted regulators in cancer glucose metabolism.

Metabolism procedures Key molecules Potential targets Biological effects Refs
Glycolysis process p53 GLUT1 and GLUT4 Prevent the glucose uptake [32]
HIF-1 GLUT1 and GLUT3 Promote the glucose entry into the tumor cells [48]
HIF-1 HK2 Enhance the phosphorylation of glucose [49]
HIF-1 LDHA and MCT4 Facilitate the conversion of pyruvate to lactate and the removal of lactate from tumor cells [51]
TIGAR Fructose-2, 6-bisphosphate Decrease the glycolytic rate [63]
TIGAR NADPH Lower the intracellular ROS level [67]
miR-143 HK2 Reduce glucose metabolism and inhibit tumor cell proliferation [79]
miR-155 STAT3 and C/EBPβ Control the aerobic glycolysis of tumor cells [81]
miR-195-5p GLUT3 Suppress the glucose uptake, inhibit tumor cell growth and promote apoptosis of tumor cells [82]
Oxidative phosphorylation process p53 SCO2 and GLS2 Increase the use of TCA cycle and up-regulate the rate of oxidative phosphorylation [34, 35]
HIF-1 PDK1, MXI1 and COX4 Repress mitochondrial activities and decrease oxygen consumption in hypoxia [52]
miR-141, miR-200a p38α Control tumor oxidative stress response and regulate redox potential [83]

Abbreviation: GLUT1: Glucose transporter 1; SCO2: Synthesis of cytochrome c oxidase 2; GLS2: Glutaminase 2; TCA cycle: Tricarboxylic acid cycle; HIF-1: Hypoxia-inducible factor 1; HK2: Hexokinase 2; LDHA: Lactate dehydrogenase A; MCT4: Monocarboxylate transporter 4; PDK1: Pyruvate dehydrogenase kinase 1; MXI1: Max interactor 1; COX4: Cytochrome c oxidase subunit 4.